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was measured using four different scores (Charlson Comorbidity Index,
Electronic Frailty Index, count of drugs prescribed, count of primary
care interactions). The outcome was total hip replacement, evaluated
using Kaplan-Meier survival and competing-risk analyses.
Results: 28,025 patients were included. 10,948 patients underwent total
hip replacement. Increased multimorbidity burden was associated
with decreased likelihood of undergoing surgery, irrespective of the
method of scoring multimorbidity. Electronic Frailty Index had the larg-
est difference between categories. Adjusted hazard ratio (‘severe multi-
morbidity versus ‘fit’) was 0.34 (95% CI 0.22, 0.51).
Conclusions: Patients with hip osteoarthritis and concurrent multi-
morbidity were up to two thirds less likely to undergo total hip replace-
ment. Whether this difference in healthcare management is
appropriate depends on to what extent multimorbidity influences the
outcomes of total hip replacement.
1272 Tension Band Wire vs Apex Intramedullary Fusion
gery to remove wires. This study compares outcomes of PIPJ fusion us-
ing traditional TBW with the newer Apex intramedullary implant and
examines its cost-effectiveness.
Method: A retrospective analysis of 50 PIPJ fusions was performed in 37
consecutive patients using either TBW or Apex implant at a single unit
between January 2013 and March 2020. Clinical and radiographic pre-
and post-operative records were reviewed by two independent sur-
geons. The primary outcome measure was successful fusion of the
joint, and complications or further surgery recorded as secondary out-
comes. Cost-benefit analysis was performed to determine overall cost
of procedure and any subsequent treatments.
Results: The TBW and Apex groups were comparable as to age, gender,
diagnoses, and comorbidities. 27 fusions were performed using TBW
compared with 23 fusions using Apex implant. Both cohorts demon-
strated 100% union rates. 10 fusions (37%) from TBW group required re-
moval of symptomatic metalwork at a mean 14.7 (6 10.9) months
compared to none in the Apex cohort.
Conclusions: PIPJ fusion using the Apex implant demonstrated equiva-
lent fusion rates to TBW and no additional surgery to remove hardware
was required. The Apex implant has an additional cost of £655 (plus
loan charge) but given that 37% of TBWs required further removal of
metalwork, overall, the Apex implant proved to be cost effective. This
study supports the use of the Apex implant as a favourable alternative
to TBW.
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Introduction: Limited data are available on the influence of multimor-
bidity on the outcomes of total hip replacement for patients with hip
osteoarthritis, including the rate of complications and degree of func-
tional benefit. The aim of this study was to investigate the influence of
multimorbidity on the outcomes of total hip replacement in the UK.
Method: A cohort study was performed, with cohort comprised of all
patients over 65 years with a diagnosis of hip osteoarthritis recorded in
Clinical Practice Research Datalink and receipt of primary total hip re-
placement recorded in Hospital Episode Statistics Admitted Patient
Care. Severity of multimorbidity burden was measured using four dif-
ferent scores (Charlson Comorbidity Index, Electronic Frailty Index,
count of drugs prescribed, count of primary care interactions). The out-
comes were (i) the risks of total hip replacement, assessed by serious
post-operative complications within 90 days (analysed with logistic re-
gression), and (ii) the benefits of surgery, assessed by post-operative
Oxford Hip Score (OHS) and EQ-5D quality of life score (analysed with
linear regression).
Results: 6,682 patients were included. The rate of complications was
3.2%. Patients with severe multimorbidity burden were at 1.5 to 2.5
times increased risk of complications than patients without multimor-
bidity. There was no clinically meaningful difference in the benefits of
surgery between patients with and without multimorbidity, irrespec-
tive of the method of scoring multimorbidity.
Conclusions: Even for patients with severe multimorbidity burden, the
potential benefits of total hip replacement for osteoarthritis remain
substantial, while the increase in risk is relatively small.
1283 The Management of Multiple Morton’s Neuromas in the
Same Foot: A Systematic Review
and assess the efficacy of current treatment strategies.
Method: A systematic review was performed using the PRISMA guide-
lines. The review is registered in the international prospective regis-
ter of systematic reviews (CRD42020213631). A computer-based
search was completed in PubMed, Embase, Cinahl, Web of Science,
Scopus and Emcare, for articles reporting the treatment of multiple
neuromas in the same foot. Two authors independently performed
title/abstract and full text screening according to a-priori selection
criteria. Considering the four studies reporting treatment of a cohort
containing both patients with a single neuroma and those with
multiple neuromas, the proportion of cases in the latter group was
51/354 (14.41%).
Results: A total of 253 articles were identified, with 7 articles, involving
383 patients being included in the review. The most common treat-
ment strategy reported was simultaneous neuroma excision using a
single incision, whilst two studies each describe simultaneous excision
with two separate incisions and delayed excision, respectively. The
proportion of patients
Discussion: There is no strong evidence favouring use of delayed
excision or multiple incisions. However, there is currently a lack of evi-
dence focusing on this presentation of neuroma specifically. A number
of studies fail to separate results of single and multiple neuroma exci-
sion. Further high-quality research is therefore required to make more
definitive conclusions and future research should investigate other




st compared to the
standards set out by the Glasgow virtual fracture clinic pathway. As a
secondary aim the effectiveness of the VFC in diverting patients not re-
quiring further clinical management away from face-to-face specialist
physical fracture clinics (PFC) was assessed.
Method: Outcomes of 1st attendances were collected for standard
PFC’s before the implementation of the VFC at our centre. This data
was comparatively analysed to the outcomes of 1st ‘attendances’ of
VFCs post-service implementation. To assess VFC referral quality frac-
ture type was recorded and compared to the standard set out by the
Glasgow virtual fracture pathway which states that a selection of sim-
ple stable fractures should be discharged from ED directly with patient
advice and telephone support.
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